and SaOS2 osteoblasts were treated with various concentration of 1,25D3 for 3 days to measure (A) cell viability and (B) cell toxicity (MG63;n=9 and SaOS2;n=10), and (C) ALP activity (n=8). (D) 293T cells were transfected with osteoblast specific 4 promoters (ALP, BSP, OSE, and OCN), followed by incubation for 48h, treatment with 1,25D3 for 24h, analysis with Luciferase assay (n=4). The Mann-Whitney U test was performed to determine statistical significance. Data are presented as means ± SDs. P values indicate significant differences between the two groups. *p<0.05; **p <0.01.
Supplementary Figure 3
Figure S3. Effect of 1,25D3 on osteogenic differentiation in both MG63 and SaOS2. Both MG63 and SaOS2 (1E4 cells) were seeded on 96 wells plate in growth medium. Next day, the medium changed with osteogenic medium (ascorbic acid, beta-glycerolphosphate, and dexamethasone). Osteogenic medium was changed every 3 days. As indicated day, the cells were subjected to ALP and ARS staining. Independent experiments were performed four times. 
Gene

5' ------Forward ------3' 5'------Reverse ------3'
18s RNA GTAACCCGTTGAACCCCATTC CCATCCAATCGGTAGTAGCG 
OSTEOPROTEGERIN (OPG) CCTGGCACCAAAGTAAACGC GCACGCTGTTTTCACAGAGG
RANKL
GCGTCGGCCTGTTCTTCTAT TGACTCTCCAGAGTTGTGTCT
RUNX2
ACGAGCTGAACAGGAACAACGT CACCAGCAAGAAGAAGCCTTTG
C/EBPβ
Supplementary methods
Measurements of cell viability and toxicity
EZ-CYTOX (EZ-1000, Dogen, Seoul, Korea) and EZ-LDH (DG-LDH1000, Dogen, Seoul, Korea) were used to quantify relative cells viability and toxicity, respectively. Assays were performed according to the manufacturer's instructions.
Gene transfer
Osteoblasts were transfected with siRNA or plasmids using Lipo3000 (Thermo Fisher, 32106) and incubated for 48 h. The cells were then stimulated for 24 h as indicated and subjected to qRT-PCR to evaluate mRNA levels and immunoblotting to evaluate protein levels.
qRT-PCR and immunoblotting
RNA and proteins were extracted from the stimulated cells with Nucleozol and 1× RIPA buffer, respectively. Complementary DNA was generated from 1 μg of total RNA with reverse transcriptase (Thermo Scientific, #EP0442). The cells were lysed with 1× RIPA buffer which included phosphatase (Cell signal, 5870S) and protease (Calbiochem, #535140) inhibitors and quantified with a Bradford assay. A total of 20~50 μg of protein were subjected to immunoblotting. Primary antibodies and primers information are given in Supple. Table 1 and   Table 2 , respectively.
Immunofluorescence
Cells grown on cover slips were fixed with ice-cold absolute methanol for 10 min. Cells were permeabilized and blocked with 0.3% Triton X-100 and 3% FBS in 1× PBS for 1 h at room temperature and then incubated with the appropriate primary antibodies in 0.1% Triton X-100
and 3% BSA in 1× PBS overnight at 4C. Antibody binding was visualized using secondary antibodies: Alexa Fluor 488-conjugated goat anti-mouse antibody (Invitrogen, A-11001) or
Cy3-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch, . Nuclei were counterstained with DAPI (VECTOR, H-1200). Immunofluorescence images were analyzed by confocal microscopy (Leica Microsystems, Wetzlar, Germany). The primary antibodies that were used are listed in Table 1 .
Constructions for deletion mutants of human RANKL promoter
Human RANKL promoter was cloned by PCR from pGL2-Basic-RANKLpromoter. The constructs were obtained using forward primers ( 
